Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Open Source Software
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
Expression patterns of inhibitor of apoptosis proteins in malignant pleural mesothelioma.
Inhibitor of apoptosis proteins are regulated by tumour necrosis factor-alpha in malignant pleural mesothelioma.
Four-gene expression ratio test for survival in patients undergoing surgery for mesothelioma.
Fine-needle aspiration biopsies for gene expression ratio-based diagnostic and prognostic tests in malignant pleural mesothelioma.
Epithelial malignant pleural mesothelioma after extrapleural pneumonectomy: stratification of survival with CT-derived tumor volume.
Hyperthermic intraoperative pleural cisplatin chemotherapy extends interval to recurrence and survival among low-risk patients with malignant pleural mesothelioma undergoing surgical macroscopic complete resection.
Proposed adjustments to pathologic staging of epithelial malignant pleural mesothelioma based on analysis of 354 cases.
Phase I to II study of pleurectomy/decortication and intraoperative intracavitary hyperthermic cisplatin lavage for mesothelioma.
Combined treatment with cisplatin and sirolimus to enhance cell death in human mesothelioma.
Erlotinib plus bevacizumab in previously treated patients with malignant pleural mesothelioma.
Validation of genomics-based prognostic tests in malignant pleural mesothelioma.
Preclinical studies of the proteasome inhibitor bortezomib in malignant pleural mesothelioma.
Extrapleural pneumonectomy followed by intracavitary intraoperative hyperthermic cisplatin with pharmacologic cytoprotection for treatment of malignant pleural mesothelioma: a phase II prospective study.
Sequential binary gene ratio tests define a novel molecular diagnostic strategy for malignant pleural mesothelioma.
Clinical indications and results after chest wall resection for recurrent mesothelioma.
Clinicopathologic characteristics of malignant mesotheliomas arising in patients with a history of radiation for Hodgkin and non-Hodgkin lymphoma.
Gender-Specific Molecular and Clinical Features Underlie Malignant Pleural Mesothelioma.
Validation of a Gene Expression Test for Mesothelioma Prognosis in Formalin-Fixed Paraffin-Embedded Tissues.
Quantitative Clinical Staging for Patients With Malignant Pleural Mesothelioma.